| Literature DB >> 34417837 |
A C Kaya1, M P Radosa2, J S M Zimmermann3, L Stotz3, S Findeklee3, A Hamza3,4, P Sklavounos3, F Z Takacs3, G Wagenpfeil5, C G Radosa6, E F Solomayer3, J C Radosa3.
Abstract
PURPOSE: The aims of this study were to determine the incidence of intraoperative and postoperative complications of laparoscopic gynecological interventions and to identify risk factors for such complications.Entities:
Keywords: Gynecology; Hysterectomy; Laparoscopy; Minimally invasive surgery; Postoperative complication
Mesh:
Year: 2021 PMID: 34417837 PMCID: PMC8490211 DOI: 10.1007/s00404-021-06192-7
Source DB: PubMed Journal: Arch Gynecol Obstet ISSN: 0932-0067 Impact factor: 2.344
Patient characteristics and surgical parameters
| Patient characteristics and surgical parameters ( | |
|---|---|
| Median (minimum–maximum) | |
| Age (years) | 42 (9–95) |
| Weight (kg) | 68 (33–172) |
| Body mass index (kg/m2) | 25.1 (15.6–62.5) |
| Operative time (min) | 82 (2–492) |
| Carbon dioxide use (l) | 156 (7.4–2060) |
| Hemoglobin drop (g/dl) | 1 (− 4.2–8.5) |
| Length of hospital stay (days) | 3 (0–75) |
| Indication | |
| Benign adnexal finding | 900 (26.9%) |
| Uterus myomatosus | 823 (24.6%) |
| Endometriosis | 537 (16.0%) |
| Others | 494 (14.7%) |
| Urogynecological | |
| Indication | 162 (4.8%) |
| Endometrial cancer | 151 (4.5%) |
| Cervical cancer | 131 (3.9%) |
| Malignant adnexal finding | 115 (3.4%) |
| CIN | 38 (1.1%) |
| Malignancy | |
| Yes | 421 (12.6%) |
| No | 2930 (87.4%) |
| Barakat-classification | |
| Grade II | 2484 (74.1%) |
| Grade III | 461 (13.8%) |
| Grade IV | 345 (10.3%) |
| Grade I | 61 (1.8%) |
| ASA–classification | |
| Grade II | 2080 (62.1%) |
| Grade I | 880 (26.3%) |
| Grade III | 386 (11.5%) |
| Grade IV | 5 (0.1%) |
| Grade V | 0 (0.0%) |
| Grade VI | 0 (0.0%) |
| Adhesiolysis | |
| Yes | 1950 (58.2%) |
| No | 1401 (41.8%) |
CIN cervical intraepithelial neoplasia, ASA-Classification American Society of Anaesthesiologists Classification (n = 3351)
Intra- and postoperative complications
| Intra- and postoperative complications ( | |
|---|---|
| Intraoperative complications | Total (%) |
| Yes | 188 (5.6%) |
| No | 3163 (94.4%) |
| Type of complication | |
| Conversion to laparotomy | 92 (2.7%) |
| | |
| | |
| Organ injury | 75 (2.2%) |
| Blood transfusion | 17 (0.5%) |
| Resuscitation | 2 (0.1%) |
| Skin emphysema | 1 (0.02%) |
| Bleeding | 1 (0.02%) |
| Postoperative complications | |
| Yes | 219 (6.5%) |
| No | 3132 (93.5%) |
| Type of complication | |
| CD IIIb | 90 (2.7%) |
| CD II | 65 (1.9%) |
| CD I | 27 (0.8%) |
| CD IVa | 24 (0.7%) |
| CD IIIa | 11 (0.3%) |
| CD V | 3 (0.1%) |
| CD IVb | 0 (0.0%) |
| Clinical manifestation of postoperative complications | |
| Bleeding/hematoma-revision | 41 (1.2%) |
| Infection/antibiotics/hematoma/abscess | 28 (0.8%) |
| Anemia requiring transfusion | 26 (0.8%) |
| Pain/adhesions | 23 (0.7%) |
| Intestinal injury/peritonitis/anastomosis insufficiency/fistula-operative therapy | 18 (0.5%) |
| Cardiopulmonal/thrombosis/embolism | 13 (0.4%) |
| Vaginal cuff dehiscence-operative therapy | 12 (0.4%) |
| Others | 12 (0.4%) |
| Abscess-operative therapy | 8 (0.2%) |
| Ileus-conservative therapy | 7 (0.2%) |
| Ileus-operative therapy | 5 (0.1%) |
| Nerve lesion/paresthesia | 5 (0.1%) |
| Bladder injury/ureter injury/vesicovaginal fistula-operative therapy | 4 (0.1%) |
| Wound healing disorder-operative therapy | 4 (0.1%) |
| Vaginal cuff dehiscence-conservative therapy | 3 (0.1%) |
| Multiorgan disfunction/death | 3 (0.1%) |
| Trocar site hernia/infection | 2 (0.1%) |
| Wound healing disorder-conservative therapy | 2 (0.1%) |
| Compartment syndrome/ limb ischemia | 2 (0.1%) |
| Lymphocele | 1 (0.02%) |
CD Clavien Dindo (n = 3351)
Surgical parameters in correlation with intraoperative complications
| Surgical parameters in correlation with intraoperative complications ( | |||
|---|---|---|---|
| Intraoperative complications | |||
| Yes | No | ||
| Total (%) | |||
| Indication | ≤ 0.01 | ||
| Uterus myomatosus | 44 (23.4%) | 779 (24.6%) | |
| Benign adnexal finding | 35 (18.6%) | 865 (27.3%) | |
| Malignant adnexal finding | 31 (16.5%) | 84 (2.7%) | |
| Endometrial cancer | 23 (12.2%) | 128 (4.0%) | |
| Cervical cancer | 17 (9.0%) | 114 (3.6%) | |
| Endometriosis | 16 (8.5%) | 521 (16.5%) | |
| Others | 16 (8.5%) | 478 (15.1%) | |
| Urogynaecological indication | 6 (3.2%) | 156 (4.9%) | |
| CIN | 0 (0.0%) | 38 (1.2%) | |
| Malignancy | ≤ 0.01 | ||
| Yes | 76 (40.4%) | 345 (10.9%) | |
| No | 112 (59.6%) | 2818 (89.1%) | |
| Barakat-classification | ≤ 0.01 | ||
| Grade II | 87 (46.3%) | 2397 (75.8%) | |
| Grade IV | 69 (36.7%) | 276 (8.7%) | |
| Grade III | 32 (17.0%) | 429 (13.6%) | |
| Grade I | 0 (0.0%) | 61 (1.9%) | |
| ASA-classification | ≤ 0.01 | ||
| Grade II | 109 (58.0%) | 1971 (62.3%) | |
| Grade III | 51 (27.1%) | 335 (10.6%) | |
| Grade I | 27 (14.4%) | 853 (27.0%) | |
| Grade IV | 1 (0.5%) | 4 (0.1%) | |
| Adhesiolysis | 0.39 | ||
| Yes | 115 (61.2%) | 1835 (58.0%) | |
| No | 73 (38.8%) | 1328 (42.0%) | |
| Body mass index | ≤ 0.01 | ||
| Normalweight | 79 (42.0%) | 1470 (46.5%) | |
| Overweight | 38 (20.2%) | 878 (27.8%) | |
| Obesity I | 32 (17.0%) | 414 (13.1%) | |
| Obesity III | 19 (10.1%) | 112 (3.5%) | |
| Obesity II | 12 (6.4%) | 186 (5.9%) | |
| Underweight | 8 (4.3%) | 103 (3.3%) | |
CIN cervical intraepithelial neoplasia, ASA Classification American society of anaesthesiologists classification (n = 3351)
Surgical parameters in correlation with postoperative complications
| Surgical parameters in correlation with postoperative complications ( | |||
|---|---|---|---|
| Postoperative complications | |||
| Yes | No | ||
| Total (%) | |||
| Indication | ≤ 0.01 | ||
| Uterus myomatosus | 60 (27.4%) | 763 (24.4%) | |
| Benign adnexal finding | 35 (16.0%) | 865 (27.6%) | |
| Others | 30 (13.7%) | 464 (14.8%) | |
| Endometriosis | 24 (11.0%) | 513 (16.4%) | |
| Endometrial cancer | 23 (10.5%) | 128 (4.1%) | |
| Malignant adnexal finding | 20 (9.1%) | 95 (3.0%) | |
| Urogynecological indication | 15 (6.8%) | 147 (4.7%) | |
| Cervical cancer | 10 (4.6%) | 121 (3.9%) | |
| CIN | 2 (0.9%) | 36 (1.1%) | |
| Malignancy | ≤ 0.01 | ||
| Yes | 58 (26.5%) | 363 (11.6%) | |
| No | 161 (73.5%) | 2769 (88.4%) | |
| Barakat-classification | ≤ 0.01 | ||
| Grade II | 128 (58.4%) | 2356 (75.2%) | |
| Grade IV | 52 (23.7%) | 293 (9.4%) | |
| Grade III | 36 (16.4%) | 425 (13.6%) | |
| Grade I | 3 (1.4%) | 58 (1.9%) | |
| ASA-classification | ≤ 0.01 | ||
| Grade II | 127 (58.0%) | 1953 (62.4%) | |
| Grade III | 48 (21.9%) | 338 (10.8%) | |
| Grade I | 43 (19.6%) | 837 (26.7%) | |
| Grade IV | 1 (0.5%) | 4 (0.1%) | |
| Adhesiolysis | 0.03 | ||
| Yes | 143 (65.3%) | 1807 (57.7%) | |
| No | 76 (34.7%) | 1325 (42.3%) | |
| Body mass index | 0.06 | ||
| Normalweight | 90 (41.1%) | 1459 (46.6%) | |
| Overweight | 61 (27.9%) | 855 (27.3%) | |
| Obesity I | 32 (14.6%) | 414 (13.2%) | |
| Obesity III | 17 (7.8%) | 114 (3.6%) | |
| Obesity II | 13 (5.9%) | 185 (5.9%) | |
| Underweight | 6 (2.7%) | 105 (3.4%) | |
| Intraoperative complications | ≤ 0.01 | ||
| Yes | 62 (28.3%) | 126 (4.0%) | |
| No | 157 (71.7%) | 3006 (96.0%) | |
| Type of complication | |||
| Laparoconversion | 40 (18.3%) | 52 (1.7%) | |
| Organ injury | 13 (5.9%) | 62 (2.0%) | |
| Blood transfusion | 7 (3.2%) | 10 (0.3%) | |
| Resuscitation | 1 (0.5%) | 1 (0.0%) | |
| Skin emphysema | 1 (0.5%) | 0 (0.0%) | |
| Bleeding | 0 (0.0%) | 1 (0.0%) | |
CIN cervical intraepithelial neoplasia, ASA Classification American Society of Anaesthesiologists Classification (n = 3351)
Multivariate analysis of factors associated with the occurrence of intraoperative complications
| Multivariate analysis of factors associated with the occurrence of intraoperative complications ( | |||
|---|---|---|---|
| Odds Ratio | 95% CI | ||
| Age (years) | 1.03 | 1.01–1.04 | ≤ 0.01 |
| Operative time (min) | 1.02 | 1.02–1.03 | ≤ 0.01 |
| Carbon dioxide use (l) | 0.99 | 0.99–1.00 | ≤ 0.01 |
| Indication (vs. endometriosis) | ≤ 0.01 | ||
| Malignant adnexal finding | 4.68 | 1.58–13.56 | ≤ 0.01 |
| Benign adnexal finding | 2.58 | 1.02–6.49 | 0.04 |
| Uterus myomatosus | 2.11 | 0.94–4.74 | 0.07 |
| Cervical cancer | 0.83 | 0.29–2.31 | 0.72 |
| Endometrial cancer | 0.94 | 0.32–2.69 | 0.90 |
| Urogynaecological indication | 0.41 | 0.13–1.35 | 0.14 |
| CIN | 0.00 | 0.00–1.00 | 0.99 |
| Others | 1.88 | 0.69–5.09 | 0.21 |
CIN cervical intraepithelial neoplasia, 95% CI 95% confidence interval, vs. versus (n = 3351)
Multivariate analysis of factors associated with the occurrence of postoperative complications
| Multivariate analysis of factors associated with the occurrence of postoperative complications ( | |||
|---|---|---|---|
| Odds ratio | 95% CI | ||
| Operative time (min) | 1.01 | 1.01–1.02 | ≤ 0.01 |
| Carbon dioxide use (l) | 0.99 | 0.99–1.00 | ≤ 0.01 |
| Hemoglobin drop (g/dl) | 1.41 | 1.21–1.65 | ≤ 0.01 |
| ASA-classification | 0.04 | ||
| I vs. II | 1.05 | 0.70–1.58 | 0.81 |
| I vs. III | 1.76 | 1.05–2.95 | 0.03 |
| I vs. IV | 6.57 | 0.65–66.63 | 0.11 |
ASA-Classification American Society of Anaesthesiologists Classification, 95% CI 95% confidence interval; vs. = versus (n = 3351)